Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Reclast (Zoledronic Acid) Injectiion
Company: Novartis Pharmaceuticals Corporation
Application No.:  021817
Approval Date: 04/16/2007

 

Date created: March 14, 2008

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-